Adequately treating high-risk patients with atrial fibrillation with anticoagulants in clinical practice is often a fine line. An increased risk of bleeding, as well as the increased prevalence of renal insufficiency, pose challenges for physicians.
Adequately treating high-risk patients with atrial fibrillation with anticoagulants in clinical practice is often a fine line. An increased risk of bleeding, as well as the increased prevalence of renal insufficiency, pose challenges for physicians.
Input your search keywords and press Enter.